Skip to main content
SpringerLink
Log in

Loss of S-100-positive Schwann cells is a feature of JAK2 V617F-positive myeloproliferative neoplasm

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Mesa RA, Powell H, Lasho T, Dewald G, McClure R, Tefferi A (2006) JAK2(V617) and leukemic transformation in myelofirbrosis with myeloid metaplasia. Leuk Res 30(11):1457–1460

    Article  CAS  PubMed  Google Scholar 

  2. Nangalia J, Massie CE, Baxter EJ, Nice FL, Gundem G, Wedge DC et al (2013) Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. N Engl J Med 369:2391–2405

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Levine RL et al (2005) Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell 7:387–397

    Article  CAS  PubMed  Google Scholar 

  4. Zhao H, Feng J, Seidel K, Shi S, Klein O, Sharpe P, Chai Y (2014) Secretion of shh by a neurovascular bundle niche supports mesenchymal stem cell homeostasis in the adult mouse incisor. Cell Stem Cell 14(2):160–173. doi:10.1016/j.stem.2013.12.0135

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Arranz L, Sánchez-Aguilera A, Martín-Pérez D, Isern J, Langa X, Tzankov A, Lundberg P, Muntión S, Tzeng YS, Lai DM, Schwaller J, Skoda RC, Méndez-Ferrer S (2014) Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms. Nature 512(7512):78–81

    CAS  PubMed  Google Scholar 

Download references

Statement

Ethical approval was taken from IRB.

Consent

Informed consent was obtained from all patients for being included in the study.

Conflict of interest

The authors declare that they have no competing interests.

Author information

Authors and Affiliations

  1. Department of Pathology, Institute of Liver and Biliary Sciences, New Delhi, India

    Chhagan Bihari & Archana Rastogi

  2. Department of Hematology, Institute of Liver and Biliary Sciences, New Delhi, India

    Priyanka Saxena

  3. Department of Research, Institute of Liver and Biliary Sciences, New Delhi, India

    Anupam Kumar

Authors
  1. Chhagan Bihari
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Archana Rastogi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Priyanka Saxena
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Anupam Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chhagan Bihari.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bihari, C., Rastogi, A., Saxena, P. et al. Loss of S-100-positive Schwann cells is a feature of JAK2 V617F-positive myeloproliferative neoplasm. Ann Hematol 94, 1427–1429 (2015). https://doi.org/10.1007/s00277-015-2396-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-015-2396-x

Keywords

Search

Navigation